Research Topics
| Sonal S MunsiffSummaryCountry: USA Publications
| Collaborators
|
Detail Information
Publications
Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997Sonal S Munsiff
New York City Department of Health, New York, New York 10013, USA
Emerg Infect Dis 8:1230-8. 2002..8%) patients; most had been exposed to patients diagnosed before the study period. These strains were likely transmitted in the early 1990 s when MDRTB outbreaks and tuberculosis transmission were widespread in New York...
Rifapentine for the treatment of pulmonary tuberculosisSonal S Munsiff
New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
Clin Infect Dis 43:1468-75. 2006..As with rifampin, drug-drug interactions are common, and regular patient monitoring is required. Ease of administration makes this regimen attractive both for tuberculosis-control programs and for patients...
Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999Sonal S Munsiff
Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, New York 10013, USA
J Infect Dis 188:356-63. 2003..This strain was disseminated widely in the community during the outbreaks; postoutbreak cases likely represent reactivated disease among individuals infected during the outbreak periods in the community...
Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003Sonal S Munsiff
Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
Clin Infect Dis 42:1702-10. 2006..Two drug-resistance surveys showed a very high prevalence of drug resistance among isolates obtained from patients with tuberculosis in 1991 and 1994 in New York, New York...
Strain-specific differences in two large Mycobacterium tuberculosis genotype clusters in isolates collected from homeless patients in New York City from 2001 to 2004Michelle Macaraig
New York City Department of Health and Mental Hygiene, 225 Broadway, 22nd Floor, New York, NY 10007, USA
J Clin Microbiol 44:2890-6. 2006....
Universal genotyping in tuberculosis control program, New York City, 2001-2003Carla M Clark
Tuberculosis Control Program, New York City Department of Health and Mental Hygiene, 225 Broadway, New York, NY 10007, USA
Emerg Infect Dis 12:719-24. 2006..Four additional TB cases were identified as a result of case finding initiated through cluster investigations. Length of unnecessary treatment decreased among patients with false-positive cultures...
Which patients' factors predict the rate of growth of Mycobacterium tuberculosis clusters in an urban community?Cynthia R Driver
Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
Am J Epidemiol 164:21-31. 2006..78). The rate of genotype cluster growth should be monitored regardless of how long the strain has been present in the community. However, infectiousness in the first two cases may be useful to prioritize genotype cluster investigations...
Human immunodeficiency virus counseling, testing, and referral of close contacts to patients with pulmonary tuberculosis: feasibility and costsJiehui Li
Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 1007, USA
J Public Health Manag Pract 13:252-62. 2007....
Prevalence of tuberculin skin test positivity and conversions among healthcare workers in New York City during 1994 to 2001Sharlette Cook
New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, New York City, New York 10013, USA
Infect Control Hosp Epidemiol 24:807-13. 2003..Continued surveillance of occupational TB infection is needed, especially among high-risk HCWs...
Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000Jiehui Li
Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY 10007, USA
Clin Infect Dis 41:83-91. 2005..The relationship between rifamycin use and either relapse or treatment failure with acquired rifampin resistance (ARR) among human immunodeficiency virus (HIV)-infected patients with tuberculosis (TB) is not well understood...
Tuberculosis in health care workers during declining tuberculosis incidence in New York StateCynthia R Driver
Bureau of Tuberculosis Control, Department of Health and Mental Hygiene, New York, NY, USA
Am J Infect Control 33:519-26. 2005..Nosocomial tuberculosis (TB) transmission has decreased dramatically in New York State since 1992; however, health care workers (HCWs) still compose >3% of TB cases...
Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009Bianca R Perri
Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, 225 Broadway, 22nd Floor, CN 72B, New York, NY 10007, USA
Emerg Infect Dis 17:372-8. 2011..tuberculosis. The photographic method would have been more successful if used earlier in the investigation. Name-based contact investigation might not identify all contacts, particularly when illegal drug use is involved...
Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programsJerod N Scholten
New York City Department of Health and Mental Hygiene, New York, USA
Clin Infect Dis 37:1686-92. 2003..6; 95% CI, 1.02-57.1); a CD4+ T lymphocyte count of <200 cells/mm3 (HR 6.6; 95% CI, 1.7-25.9); and tuberculin positivity (HR 4.0; 95% CI, 1.6-10.2). Treatment with isoniazid was beneficial in HIV-infected, tuberculin-positive IDUs...
Adherence to treatment of latent tuberculosis infection in a clinical population in New York CityJiehui Li
New York City Department of Health and Mental Hygiene NYCDOHMH, 26th Floor, New York, NY 10279 2600, USA
Int J Infect Dis 14:e292-7. 2010..Low adherence to treatment of latent tuberculosis infection (TLTBI) diminishes TB prevention efforts. This study examined the treatment completion rate among those who started TLTBI and factors associated with adherence to TLTBI...
Tuberculin testing and risk of tuberculosis infection among New York City schoolchildrenCeline R Gounder
Tuberculosis Control Program, New York City Department of Health, New York, New York 10007, USA
Pediatrics 111:e309-15. 2003....
Performance of nucleic acid amplification tests for diagnosis of tuberculosis in a large urban settingFabienne Laraque
Bureau of Tuberculosis Control, New York City Department of Health of Mental Hygiene, New York 10013, USA
Clin Infect Dis 49:46-54. 2009..We evaluated the performance of NAA testing under field conditions in a large urban setting with moderate TB prevalence...
TuberculosisThomas R Frieden
New York City Department of Health and Mental Hygiene, New York, NY 10013, USA
Lancet 362:887-99. 2003..Until tuberculosis is controlled worldwide, it will continue to be a major killer in less-developed countries and a constant threat in most of the more-developed countries...
Prevalence of tuberculin skin test positivity in clinical population in New York CityJiehui Li
New York City Department of Health and Mental Hygiene, New York, NY 10279 2600, USA
J Immigr Minor Health 12:816-22. 2010..3, 95%CI = 1.2, 1.4). These findings provide insight into current prevalence of TST positivity in many immigrant populations and will help both clinicians and health departments to target patients for LTBI treatment...
Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06Holly A Anger
New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, 225 Broadway, 22nd Floor, New York, NY 10007, USA
J Antimicrob Chemother 65:775-83. 2010....
Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patientsJiehui Li
Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, 225 Broadway, 22nd Floor, New York, NY 10007, USA
Chest 126:1770-6. 2004....
Changing sociodemographic and clinical characteristics of tuberculosis among HIV-infected patients, New York City, 1992-2005Tiffany G Harris
New York City Department of Health and Mental Hygiene, New York, New York, USA
Clin Infect Dis 50:1524-31. 2010..Although highly active antiretroviral therapy (HAART) has decreased human immunodeficiency virus (HIV)-related morbidity, tuberculosis remains an important disease among HIV-infected individuals...
Factors associated with tuberculosis treatment interruption in New York CityCynthia R Driver
Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, 225 Broadway, 22nd Floor, New York, NY 10007, USA
J Public Health Manag Pract 11:361-8. 2005..Large urban tuberculosis control program...
The impact of monitoring tuberculosis reporting delays in New York CityMuriel Silin
New York City Department of Health and Mental Hygiene NYC DOHMH, Bureau of TB Control, New York 10007, USA
J Public Health Manag Pract 16:E09-17. 2010..This relatively simple intervention was very effective in improving the timeliness of TB reporting and could be utilized for other reportable diseases where prompt reporting is critical...
The DOTS strategy for controlling the global tuberculosis epidemicThomas R Frieden
New York City Department of Health and Mental Hygiene, 125 Worth Street, New York, NY 10013, USA
Clin Chest Med 26:197-205, v. 2005..The relevance of DOTS in the context of multidrug-resistant tuberculosis and the HIV epidemic also is discussed...
Targeting tuberculosis testing: the yield of source case investigations for young children with reactive tuberculin skin testsCynthia R Driver
Tuberculosis Control Program, New York City Department of Health, New York, NY 10007, USA
Public Health Rep 117:366-72. 2002..This study was designed to determine the yield of investigations whose aim is to identify a source case for tuberculosis infection among tuberculin reactors 3 years of age or younger...
Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997Thomas R Frieden
Int J Tuberc Lung Dis 11:116. 2007
Management of latent tuberculosis infection in immigrantsTimothy Sterling
N Engl J Med 348:1289-92; author reply 1289-92. 2003
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosisWilliam J Burman
Denver Public Health and the Department of Medicine, University of Colorado Health Sciences National Jewish Medical and Research Center, Denver, Colorado, USA
Am J Respir Crit Care Med 174:331-8. 2006..Moxifloxacin has promising preclinical activity against Mycobacterium tuberculosis, but has not been evaluated in multidrug treatment of tuberculosis in humans...
Patients with drug-resistant tuberculosis who were treated with standardized short-course chemotherapySonal S Munsiff
Clin Infect Dis 40:1549-50. 2005
Tuberculosis prevention for non-US-born pregnant womenJudith E Sackoff
Department of Medicine Preventive Medicine and Community Health, State University of New York Downstate Medical Center, Brooklyn, NY, USA
Am J Obstet Gynecol 194:451-6. 2006..The purpose of this study was to evaluate whether non-US-born pregnant women receiving prenatal care are targeted for treatment of latent tuberculosis (TB) infection (LTBI) with isoniazid (INH) to prevent active TB...
How late after injection can a tuberculin skin test be interpreted?Sonal S Munsiff
Clin Infect Dis 41:271; author reply 271. 2005
